Dr. Ayna Durdyyeva

Dr. Ayna Durdyyeva is a hematologist at the National Centre of Oncology in Ashgabat — Turkmenistan's dedicated national cancer and hematological malignancy treatment facility. With over 13 years of clinical experience, she manages blood disorders ranging from benign anemias and coagulation problems to hematological malignancies including leukemias, lymphomas, and myeloma. Turkmenistan's National Centre of Oncology serves as the primary referral institution for hematology-oncology across the country, centralizing the diagnosis and treatment of blood cancers that require systemic chemotherapy and specialized supportive care. Dr. Durdyyeva works within multidisciplinary oncology teams that coordinate surgery, radiation, and systemic therapy for patients with hematological cancers. She also manages complex benign blood disorders including aplastic anemia, hemolytic anemias, and coagulation disorders at the specialist level. Her work is conducted within the constraints of a centrally planned healthcare system, applying evidence-based protocols to the resources available in Turkmenistan.

Dr. Durdyyeva completed her medical training at Turkmen State Medical University in Ashgabat, earning her MD through the state medical education system. Following her general medical degree, she pursued specialist certification in hematology-oncology through the Ministry of Health of Turkmenistan's approved specialist pathway, which incorporates supervised training in both hematology and oncology at the National Centre and affiliated hospitals. She subsequently participated in an advanced training programme in hematological oncology through the Commonwealth of Independent States (CIS) regional collaboration network, which provides access to updated protocols and educational resources for hematology specialists across Central Asian and post-Soviet states. Her specialty training has given her competence in bone marrow aspiration and biopsy, hematological diagnosis, and chemotherapy administration for hematological malignancies.

Dr. Durdyyeva's clinical hematology practice covers both malignant and benign blood conditions. In hematological malignancies, she manages acute leukemias (AML and ALL) with induction and consolidation chemotherapy, chronic leukemias (CML and CLL) with targeted therapy, lymphoma diagnosis and treatment, and multiple myeloma management. She performs bone marrow aspiration and trephine biopsy for diagnostic hematology and collaborates with pathology for morphological and immunohistochemical blood cancer diagnosis. In benign hematology, she evaluates and treats iron deficiency anemia, vitamin B12 and folate deficiency, hemolytic anemias, aplastic anemia, and inherited coagulation disorders. She provides supportive care for chemotherapy patients including management of neutropenic fever, anemia requiring transfusion support, and platelet disorders. She also manages anticoagulation therapy for patients with thromboembolic disease.

The National Centre of Oncology in Ashgabat serves as the country's primary resource for hematological malignancy treatment and is accessible to foreign nationals residing or working in Turkmenistan. The centralized nature of cancer care in Turkmenistan means that all significant hematological malignancy cases pass through this facility. International patients requiring bone marrow transplantation — a service not currently available within Turkmenistan — are typically referred to specialized centers in Turkey, Russia, or Germany through the Ministry of Health's international patient referral program. The healthcare system operates primarily in Turkmen and Russian; international patients should arrange for interpreter services. Expatriate workers in Turkmenistan (particularly in the oil and gas sector) often have access to international health insurance that covers medical evacuation.

Dr. Durdyyeva has been recognized by the Turkmenistan Ministry of Health and the National Centre of Oncology for her contribution to hematological malignancy management within the country's specialist cancer care system. Her participation in CIS regional hematology training programs reflects professional engagement with the broader post-Soviet medical community, where collaborative networks for oncology education and treatment protocol sharing remain active. Her sustained practice in a resource-constrained setting — applying international hematology standards within Turkmenistan's healthcare system — reflects a professional commitment to quality cancer care. She is among a small specialist hematology workforce serving the entire Turkmen population.